These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15955618)

  • 1. Models of ovarian cancer--are we there yet?
    Garson K; Shaw TJ; Clark KV; Yao DS; Vanderhyden BC
    Mol Cell Endocrinol; 2005 Jul; 239(1-2):15-26. PubMed ID: 15955618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early events in ovarian oncogenesis.
    Cvetkovic D
    Reprod Biol Endocrinol; 2003 Oct; 1():68. PubMed ID: 14577833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse molecular pathways in ovarian cancer and their clinical significance.
    Ricciardelli C; Oehler MK
    Maturitas; 2009 Mar; 62(3):270-5. PubMed ID: 19193504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological characteristics of an established model of ovarian cancer in mice and its homologous cell lines].
    Zhang ZM; Zhang C; Zhang FH; Shan BE; Nakagawa S
    Ai Zheng; 2006 Jun; 25(6):701-7. PubMed ID: 16764764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm.
    Ahmed N; Thompson EW; Quinn MA
    J Cell Physiol; 2007 Dec; 213(3):581-8. PubMed ID: 17708542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations.
    Katz E; Skorecki K; Tzukerman M
    Clin Cancer Res; 2009 Jan; 15(1):70-80. PubMed ID: 19118034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer.
    Greenaway J; Moorehead R; Shaw P; Petrik J
    Gynecol Oncol; 2008 Feb; 108(2):385-94. PubMed ID: 18036641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis.
    Okamura H; Katabuchi H
    Int Rev Cytol; 2005; 242():1-54. PubMed ID: 15598466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer.
    Popadiuk CM; Xiong J; Wells MG; Andrews PG; Dankwa K; Hirasawa K; Lake BB; Kao KR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2216-23. PubMed ID: 16609037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
    Ting AY; Kimler BF; Fabian CJ; Petroff BK
    Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression.
    Peters DG; Kudla DM; Deloia JA; Chu TJ; Fairfull L; Edwards RP; Ferrell RE
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1717-23. PubMed ID: 16030107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 -/- epithelial ovarian cancers.
    Indraccolo S; Tisato V; Agata S; Moserle L; Ferrari S; Callegaro M; Persano L; Palma MD; Scaini MC; Esposito G; Fassina A; Nicoletto O; Plebani M; Chieco-Bianchi L; Amadori A; D'Andrea E; Montagna M
    Eur J Cancer; 2006 Jul; 42(10):1475-83. PubMed ID: 16759848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
    Chien JR; Aletti G; Bell DA; Keeney GL; Shridhar V; Hartmann LC
    J Cell Biochem; 2007 Dec; 102(5):1117-29. PubMed ID: 17879946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ID8 MOSE and VEGF-modified ID8 cell lines in an immunocompetent animal model for human ovarian cancer.
    Janát-Amsbury MM; Yockman JW; Anderson ML; Kieback DG; Kim SW
    Anticancer Res; 2006; 26(4B):2785-9. PubMed ID: 16886597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
    Ruan HY; Li DR; Li L; Guan X; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ovarian surface epithelium: simple source of a complex disease.
    Choi KC; Auersperg N
    Minerva Ginecol; 2003 Aug; 55(4):297-314. PubMed ID: 14581855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in biomarker discovery for diagnostic testing in epithelial ovarian cancer.
    Gogoi R; Srinivasan S; Fishman DA
    Expert Rev Mol Diagn; 2006 Jul; 6(4):627-37. PubMed ID: 16824035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory study of ovarian intraepithelial neoplasia.
    Brewer MA; Ranger-Moore J; Baruche A; Alberts DS; Greene M; Thompson D; Liu Y; Davis J; Bartels PH
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):299-305. PubMed ID: 15734950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.